SecBot SecBot
Institutional Cluster

BCAX

Bicara Therapeutics Inc.
BEARISH
Impact 5/10
Horizonweeks Processed5mo ago
Institutional cluster: 1 buyers, 3 sellers (bearish)
Actionable Insight ▼ Bearish

The cluster is dominated by active/quant sellers (Point72, Two Sigma, Morgan Stanley) with a near-exit from Point72, while the sole buyer is a passive index fund. This suggests informed capital is rotating out. Monitor for further 13F filings next quarter to confirm trend; the stock may face continued selling pressure if the thesis weakens.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$21.28
T+0 close · Jun 11, 2026 · via day close
Latest settled
+8.88%
T+60 · $23.17
Vs SPY
+4.49%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $21.28entry
  2. T+1 · 5mo ago +1.93%α +1.39% · $21.69
  3. T+5 · 5mo ago +7.71%α +7.27% · $22.92
  4. T+20 · 4mo ago +39.47%α +37.58% · $29.68
  5. T+60 · 2mo ago +8.88%α +4.49% · $23.17

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

An institutional cluster for Bicara Therapeutics (BCAX) shows net bearish conviction in Q3 2025: 3 sellers (including a near-exit from Point72) versus 1 passive buyer (Schwab). The selling is concentrated among active/quant funds, while the sole buyer is a passive index manager, suggesting the bearish signal is more informative. Total selling value ($1.6M) outweighs buying ($2.6M net, but driven by price appreciation, not conviction).

Key Financial Metrics

Direction
distributing
Buy Value
$4.4M
Sell Value
$3.6M
Net Flow
-$1.6M

Institutional Positions

Net institutional flow: -$1.6M

▲ Buyers (1)

InstitutionActionChangePosition ValueValue Δ
SchwabADD+45.5%$4.4M$2.6M

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyTRIM-51.1%$1.9M-$320.0K
Two SigmaTRIM-29.2%$1.2M$255.0K
Point72NEAR_EXIT-86.1%$2.0M-$1.5M

Key Facts

  • 3 sellers vs 1 buyer in Q3 2025 institutional cluster
  • Point72 near-exited 86.1% of its position (from $2.0M to $476K)
  • Morgan Stanley trimmed 51.1% of its stake (from $1.9M to $1.6M)
  • Two Sigma trimmed 29.2% of its position
  • Only buyer was Schwab (passive index fund), adding 45.5% to $4.4M
  • Net dollar change across all tracked funds: -$1.6M (sellers) vs +$2.6M (buyer, largely price-driven)

Financial Impact

3 institutional sellers reduced holdings by a net of $1.6M, while 1 passive buyer added $2.6M (mostly from price appreciation). Total tracked institutional activity: $4.2M in gross turnover.

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound or reversed since quarter-end
  • Small absolute dollar amounts ($1-4M) may not be material for a $1.3B market cap stock
  • Passive buying from Schwab could offset some selling pressure

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BCAX-2025-Q3

US Market Status

Market Closed · Opens Wed (9h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026